Abstract
The suitability of 4-di(2-chloroethyl)aminoanilino-4-hydroxyphenethylaminomethanone 2 to act as a prodrug for melanocyte-directed enzyme prodrug therapy (MDEPT) is assessed. Thus its synthesis, ability to generate a cytotoxic agent upon exposure to tyrosinase, and stability within different sera are reported. A comparison is made to illustrate that the new urea prodrug 2 is a more suitable candidate for MDEPT than the corresponding carbamate prodrug 1.
Original language | English |
---|---|
Pages (from-to) | 2625-33 |
Number of pages | 9 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 10 |
Issue number | 8 |
Publication status | Published - Aug 2002 |
Keywords
- Animals
- Blood
- Carbamates
- Cattle
- Cell Death
- Drug Delivery Systems
- Drug Stability
- Enzymes
- Humans
- Melanocytes
- Monophenol Monooxygenase
- Prodrugs
- Urea